Collaborative trial platforms position themselves as the best method to achieve a drug for non-alcoholic fatty liver disease

by Vall d’Hebron

Collaborative platform trials subject patients to a unique selection process that makes them candidates for several treatment arms at the same time. The idea is to unify data analysis and standardize ...

Read more

Non-Alcoholic Steatohepatitis (NASH) Mechanisms and Models to Bring Attention to This Growing Epidemic

by CYTES BIOTECHNOLOGIES, SL.

Non-alcoholic steatohepatitis (NASH) is the advanced form of non-alcoholic fatty liver disease (NAFLD) characterized by an accumulation of fat in the liver cells that causes inflammation, ballooning o...

Read more

New key mechanism in the development of non-alcoholic fatty liver disease identified

by CIC bioGUNE

Alterations in neddylation have been shown to be involved in some liver diseases such as liver cancer, fibrosis and cirrhosis, and now in the development of non-alcoholic fatty liver disease. Pharmac...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream